​SG Eyes Pharma, Biotech Offering As M&A Spikes

May 13, 2015

Société Générale is to launch open-end certificates on a pharma and biotech opportunity index to retail and private banking clients in Germany and Austria following increased M&A activity in the healthcare industry.

Restricted content

You must be an EQD+ subscriber to view this page. Either sign in or see below on how to request a trial.